SEC Form 4 · accession 0001209191-17-023533
BIOCEPT INC · BIOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ivor Royston
Director
Period of report
Mar 16, 2015
Accepted (ET)
Mar 29, 2017 · 4:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001044378
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Mar 16, 2015 | P | 5,667 | $8.76 | A | 17,294 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 34,584 fewer shares.
- F2The number of shares and purchase price shown in column 4 above are reflected on a post-split basis.
- F3The number of shares reflected in column 5 above reflects the Reporting Person's ownership as of March 29, 2017.